Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Figure S4 from Brexucabtagene Autoleucel versus Allogeneic Hematopoietic Cell Transplantation in Relapsed and Refractory Mantle Cell Lymphoma
  1. Home
  2. Publications
  3. Figure S4 from Brexucabtagene Autoleucel versus Allogeneic Hematopoietic Cell Transplantation in Relapsed and Refractory Mantle Cell Lymphoma

Figure S4 from Brexucabtagene Autoleucel versus Allogeneic Hematopoietic Cell Transplantation in Relapsed and Refractory Mantle Cell Lymphoma

Authors:
  • NLNora Liebers
    Nora Liebers
  • ABAriane Boumendil
    Ariane Boumendil
  • HFHervé Finel
    Hervé Finel
  • DEDominic Edelmann
    Dominic Edelmann
  • GKGuido Kobbe
    Guido Kobbe
  • BBBen-Niklas Baermann
    Ben-Niklas Baermann
  • YSYasmina Serroukh
    Yasmina Serroukh
  • DBDidier Blaise
    Didier Blaise
  • DBDietrich Wilhelm Beelen
    Dietrich Wilhelm Beelen
  • CSCarlos Solano
    Carlos Solano
  • MIMaija Itälä-Remes
    Maija Itälä-Remes
  • TMTom van Meerten
    Tom van Meerten

Open Access
Publisher website
Google Scholar
  • 17 June 2026
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/2643-3230.32696679
Abstract
Comparison of ZUMA-2 and alloHCT population for Overall survival (OS), Progression-free survival (PFS), Non-relapse mortality (NRM) and incidence of relapse (IR) in unmatched cohorts.
Keywords
  • HEMATOLOGICAL CANCERS
  • LYMPHOMAS
  • IMMUNOTHERAPY
  • CELLULAR IMMUNOTHERAPY
  • ENGINEERED/CAR T CELLS
  • STEM CELL TRANSPLANTATION
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.